These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 25320371)

  • 81. Tumor immunity against adult T-cell leukemia.
    Kannagi M; Harashima N; Kurihara K; Ohashi T; Utsunomiya A; Tanosaki R; Masuda M; Tomonaga M; Okamura J
    Cancer Sci; 2005 May; 96(5):249-55. PubMed ID: 15904464
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies.
    Hermine O; Ramos JC; Tobinai K
    Adv Ther; 2018 Feb; 35(2):135-152. PubMed ID: 29411267
    [TBL] [Abstract][Full Text] [Related]  

  • 83. KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target.
    Cheminant M; Lhermitte L; Bruneau J; Sicard H; Bonnafous C; Touzart A; Bourbon E; Ortonne N; Genestier L; Gaulard P; Palmic P; Suarez F; Frenzel L; Naveau L; Bazarbachi A; Dussiot M; Waast L; Avettand-Fenoel V; Brouzes C; Pique C; Lepelletier Y; Asnafi V; Marçais A; Hermine O
    Blood; 2022 Sep; 140(13):1522-1532. PubMed ID: 35687761
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Multidisciplinary insight into clonal expansion of HTLV-1-infected cells in adult T-cell leukemia via modeling by deterministic finite automata coupled with high-throughput sequencing.
    Farmanbar A; Firouzi S; Park SJ; Nakai K; Uchimaru K; Watanabe T
    BMC Med Genomics; 2017 Jan; 10(1):4. PubMed ID: 28137248
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Human T lymphotropic virus-1 infection.
    Kanzaki T; Setoyama M; Katahira Y
    Australas J Dermatol; 1996 May; 37 Suppl 1():S20-2. PubMed ID: 8713005
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Genetic instability of adult T-cell leukemia/lymphoma by comparative genomic hybridization analysis.
    Tsukasaki K
    J Clin Immunol; 2002 Mar; 22(2):57-63. PubMed ID: 11998893
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Adult T Cell Leukemia-Lymphoma (ATL): State of the Art.
    Phillips AA; Harewood JCK
    Curr Hematol Malig Rep; 2018 Aug; 13(4):300-307. PubMed ID: 30047026
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States.
    Malpica L; Pimentel A; Reis IM; Gotuzzo E; Lekakis L; Komanduri K; Harrington T; Barber GN; Ramos JC
    Blood Adv; 2018 Mar; 2(6):607-620. PubMed ID: 29545256
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clinical features and treatment outcomes of opportunistic infections among human T-lymphotrophic virus type 1 (HTLV-1) carriers and patients with adult T-cell leukemia-lymphoma (ATL) at a single institution from 2006 to 2016.
    Kawano N; Nagahiro Y; Yoshida S; Tahara Y; Himeji D; Kuriyama T; Tochigi T; Nakaike T; Shimokawa T; Yamashita K; Ochiai H; Marutsuka K; Mashiba K; Shimoda K; Teshima T; Kikuchi I
    J Clin Exp Hematop; 2019; 59(4):156-167. PubMed ID: 31866618
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive Review.
    Nakahata S; Enriquez-Vera D; Jahan MI; Sugata K; Satou Y
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892225
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Adult T-cell leukemia in Japan.
    Takatsuki K; Matsuoka M; Yamaguchi K
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S15-9. PubMed ID: 8797698
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma.
    Katsuya H; Ishitsuka K
    J Clin Exp Hematop; 2017 Dec; 57(3):87-97. PubMed ID: 28592744
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type 1 carriers in Japan.
    Satake M; Yamada Y; Atogami S; Yamaguchi K
    Leuk Lymphoma; 2015 Jun; 56(6):1806-12. PubMed ID: 25219595
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Application of HTLV-1 tax transgenic mice for therapeutic intervention.
    Hasegawa H; Sano K; Ainai A; Suzuki T
    Adv Biol Regul; 2018 May; 68():10-12. PubMed ID: 29588208
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Novel Treatments of Adult T Cell Leukemia Lymphoma.
    El Hajj H; Tsukasaki K; Cheminant M; Bazarbachi A; Watanabe T; Hermine O
    Front Microbiol; 2020; 11():1062. PubMed ID: 32547515
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [New treatment strategy for adult T-cell leukemia targeting for anti-tumor immunity and a longevity gene-encoded protein].
    Kozako T
    Yakugaku Zasshi; 2011; 131(7):1061-72. PubMed ID: 21720136
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Adult T-cell leukemia/lymphoma].
    Yoshimitsu M
    Rinsho Ketsueki; 2023; 64(9):1032-1040. PubMed ID: 37899180
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I.
    Murphy EL; Hanchard B; Figueroa JP; Gibbs WN; Lofters WS; Campbell M; Goedert JJ; Blattner WA
    Int J Cancer; 1989 Feb; 43(2):250-3. PubMed ID: 2917802
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course.
    Tsukasaki K; Krebs J; Nagai K; Tomonaga M; Koeffler HP; Bartram CR; Jauch A
    Blood; 2001 Jun; 97(12):3875-81. PubMed ID: 11389029
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Human T-cell leukemia virus-associated malignancy.
    Panfil AR; Martinez MP; Ratner L; Green PL
    Curr Opin Virol; 2016 Oct; 20():40-46. PubMed ID: 27591679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.